Pure Global AI
NCT06413732Completed

The Effect of Dual Task Training in Patients With Stroke

The Effect of Dual Task Training on Gait, Balance, and Quality of Life in Patients With Stroke
Karabuk UniversityClinicalTrials.govother
Study focus
Disease/Condition
Stroke
Drug/Device/Intervention
Conventional physiotherapy
Study type
Interventional
Intervention type
other
Sponsor & location
Primary sponsor
Karabuk University
Location
Karabuk, Turkey
Timeline & enrollment
Phase
N/A
Start date
Sep 01, 2022
End date
Jan 31, 2024
Enrollment
30 participants
Primary outcome

Berg Balance Scale,Timed Up and Go Test,10-meter walk test,30-Second Chair-Stand Test,Short Form 36

Summary

The aim of this study was to investigate the effect of dual-task training on gait, balance,
 and quality of life in individuals with stroke. The study included 30 individuals aged 30-80
 years with stroke. All participants were assessed using the 10-meter walk test (10MWT), 10MWT
 under dual-task interaction (DTI), timed up and go (TUG), 30-Second Chair-Stand Test
 (30s-CST), Berg Balance Scale (BBS), Short Form 36 (SF-36). Participants were randomized into
 two groups. Both groups received conventional physiotherapy for approximately 1 hour, five
 days a week. Group I also received dual-task training.

ICD-10 classifications
Stroke, not specified as haemorrhage or infarctionSequelae of stroke, not specified as haemorrhage or infarctionCerebral infarctionFamily history of strokeCerebral infarction, unspecified
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06413732
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06413732 through Pure Global AI's free database. This phase not specified trial is sponsored by Karabuk University and is currently Completed. The study focuses on Stroke. Target enrollment is 30 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.